Aperiomics logo horiz screen

Aperiomics, Inc.

Aperiomics' mission is to advance healthcare and revolutionize infection testing to improve human health.

  • Stage $1M in TTM Revenue
  • Industry Biotechnology
  • Location Sterling, VA, USA
  • Currency USD
  • Founded October 2013
  • Employees 9
  • Incorporation Type C-corp
  • Website

Company Summary

Aperiomics' mission is to advance healthcare through better infection testing. We are the only company identifying every known bacteria, virus, parasite, & fungus. This technology addresses a huge unmet need given that 75%+ of infections are not properly identified and thus are not properly treated.

Today Show:


  • Co-founder of Aperiomics
    Serial entrepreneur
    Molecular biology and Infectious disease training
    Kauffman Foundation Outstanding Postdoctoral Entrepreneur 2012

  • F8b93f6a 7ef1 4031 81cf ae3bb540d28f

    Co-founder of Aperiomics
    Director of Computational Biology Institute at George Washington University
    Fulbright Scholar at Oxford University
    Edward O. Wilson Naturalist Award
    Elected as Fellow in American Association for the Advancement of Science
    MA (Statistics) and PhD (Biology & Biomedical Sciences) from Washington University
    Co-founded Genoma LLC, a bioinformatics consulting company, in 2002

  • 49a08d32 51d6 4ad7 90c4 c1f858503e56
    Science Advirosory Board, Chair

    Co- founder of Aperiomics
    Assistant professor of Medicine, Biostatistics, and Bioinformatics at Boston University School of Medicine
    Developed widely used analytical methods and software for analyzing high-throughput genetic, genomic, and epigenomic profiling datasets
    MS degree in Statistics at Brigham Young University
    MA and PhD degrees in Biostatistics from Harvard University

  • Default avatar
    Eduardo Castro-Nallar, PhD
    Science Advisory Board

  • E8df88ad a8ce 45a3 8dc6 d319c45dd937

    Alvin Chen, PhD, has more than 10 years experience in next-generation sequencing and is an expert in genomics, genetics and bioinformatics. Dr. Chen joined Aperiomics in 2015 and served as PI of the an NSF SBIR Phase II grant. He successfully developed the company’s primary platform, Xplore-PATHO℠, which uses DNA sequencing technology to identify all microbes in a single test.

  • Elizabeth P. Pyle, MBA serves as Chief Operating for Aperiomics located, VA. As COO, she oversees corporate operations and quality management. Her extensive experience in business development, strategic planning, marketing, operations, and leadership will enable the company to continue on its projected growth path.


  • Default avatar
    Mary Sylvia
    Default avatar
    Scott Meza

Previous Investors

  • Default avatar
    National Science Foundation
    Default avatar
    Center for Innovative Technology
    Default avatar
    Pipeline Angels
  • Default avatar
    Default avatar
  • Default avatar
    K Street Capital